welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
-
A Proposed Staging System and Stage-Specific Interventions for Familial Adenomatous PolyposisBACKGROUND : It is not possible to accur...
-
@MyGeneCounsel#Geneticcounselor, #President & #CEO...
-
Polyposis Syndromes of the Colon Current Management, Controversies and Future Directionhttp://www.slideserve.com/verena/polypos...
-
Multistage Vector Delivery of Sulindac and Silymarin for Prevention of Colon CancerFamilial adenomatous polyposis (FAP) is ...
-
Stephen B. Gruber, MD, PhD, MPHDr. Gruber is a certified medical oncolo...
-
Health Promotion: Familial Adenomatous Polyposishttps://www.youtube.com/watch?v=H7STJHsN...
-
#hereditarycoloncancerFAP hashtag for the community...